The VCU Multiple Sclerosis Treatment and Research Center offers one-year and two-year fellowship positions in multiple sclerosis and neuroimmunology.

Fellows will train in both the inpatient and outpatient care and management of MS and MS-related disorders, as well as participate in MS therapeutic trials and other clinical research. MS and MS-related disorders require multidisciplinary care, and thus fellows will have the opportunity to work with our colleagues in fields such as physical medicine and rehabilitation, urology, ophthalmology and neuroradiology.

The program provides a flexible learning environment to meet the specific interests of the fellow, and in the second year they may pursue independent research projects in clinical, translational research, or basic science labs.

One fellowship position becomes available beginning July 1 each year.

We are nbow accepting applications for a July 2023 start. Fellowship applicants must have completed an accredited residency program in neurology in the U.S. or Canada. The fellowship does not participate in any matching programs.

Please submit the following original application materials:

  • Curriculum vitae (CV) with a current e-mail address and phone number
  • Personal statement
  • Professional photograph
  • VCU Health Systems Graduate Medical Education general application
  • Official medical school transcript
  • Test scores
    • USMLE steps 1, 2 and 3 (passing scores – no minimum)
  • Letters of recommendation: A minimum of three U.S. or Canadian physicians who know the applicant’s clinical skills and have worked with the applicant during the past two years (must be originals; no electronic copies)

Send your application materials to: 


Neuro-Immunology applicants must have completed an accredited residency program in neurology, child neurology or general psychiatry in the U.S. or Canada. For further information, please consult the ACGME and the ABPN 

After acceptance and prior to joining the program, applicants must provide a list of rotations completed during prerequisite training. This document, on letterhead from the institution where training was completed, must arrive no later than July 15. 

If you have additional questions, please don't hesitate to reach out.

Christine Rucker 

Myla Goldman, MD, MSc., Program Director & Chair